| abstract |
A pharmaceutical composition used as an anti-inflammatory is prepared. The composition comprises a plasma fraction separated from blood plasma and/or in combination with a pharmaceutical carrier. In a preferred method, the plasma fraction is separated from the blood plasma by mixing with from 3 % to 10 % by weight of the plasma fraction of silica and thereafter centrifuging to allow the plasma fraction to be precipitated out in conjunction with the silica. They are thereafter separated. |